pharmaceutical investing Inovio Closes License and Collaboration Agreement with ApolloBio To Develop and Commercialize VGX-3100 in Greater China
pharmaceutical investing Dova Pharmaceuticals Signs Exclusive Distribution Agreement with Fosun Pharma For Mainland China and Hong Kong
pharmaceutical investing Tetraphase Pharmaceuticals Enters into Exclusive Development and Commercialization Agreement with Everest Medicines
pharmaceutical investing Amarin Announces Commencement of VASCEPA® Clinical Development in Mainland China
medical device investing CVR Medical Enters China, Executes Preliminary LOI To Launch Its CSS Device In World’s Largest Market
BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer
Brixton Metals Announces Closing of Option Agreement to Acquire a 100% Interest in the Silver Focused Silvergruvan Project in Sweden
